Patents by Inventor Caroline Monnard

Caroline Monnard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for increasing T cell function
    Patent number: 12734150
    Abstract: An agent for use in reducing T cell exhaustion and/or increasing T cell function, and/or boosting immunity, wherein the agent is selected from the group consisting of nicotinamide riboside, vitamin B12, a urolithin, manganese, serine, glycine, arginine, asparagine, and a combination of two or more thereof.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: September 15, 2026
    Assignees: SOCIETE DES PRODUITS NESTLE S.A., LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
    Inventors: Nicola Vannini, George Coukos, Serge Andre Dominique Rezzi, Julie Laval, Caroline Monnard, Marcela Rincon Restrepo
  • COMPOSITIONS AND METHODS FOR INCREASING T CELL FUNCTION
    Publication number: 20220168271
    Abstract: An agent for use in reducing T cell exhaustion and/or increasing T cell function, and/or boosting immunity, wherein the agent is selected from the group consisting of nicotinamide riboside, vitamin B12, a urolithin, manganese, serine, glycine, arginine, asparagine, and a combination of two or more thereof.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 2, 2022
    Inventors: Nicola Vannini, George Coukos, Serge Andre Dominique Rezzi, Julie Laval, Caroline Monnard, Marcela Rincon Restrepo